WALTHAM, Mass., March 20 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. , announced today that it will host a conference call and webcast on Thursday, March 27, 2008 at 4:30 p.m. EDT to review the Company’s fourth quarter and year end 2007 financial results and provide an update on recent corporate developments.
To access the live call, dial 877-440-5803 (domestic) or 719-325-4900 (international). The live webcast will be available in the Investors section of the Company’s website, http://www.ilgenetics.com.
Replay access of the teleconference will be available for two weeks following the call by dialing 719-457-0820 (domestic) or 888-203-1112 (international). The passcode for the replay is 3385694. The webcast will be archived following the call at http://www.ilgenetics.com.
About Interleukin Genetics
Interleukin Genetics, Inc. is a genetics-focused personalized health company that develops preventive consumer products and genetic tests for sale to the emerging personalized health market. Focused on the future of health and medicine, Interleukin uses its leading genetics research and scientific capabilities to develop and test innovative preventive and therapeutic products. Interleukin Genetics has developed and commercialized genetic tests for risk assessment of coronary artery disease, periodontal disease, and general nutrition. The Company currently offers an array of Nutraceuticals and OTCeuticals(R), including Ginkoba(R), Ginsana(R) and Venastat(R) which are sold at the nation’s largest food, drug and mass retailers. Interleukin is headquartered in Waltham, MA. For more information about Interleukin and its ongoing programs, please visit http://www.ilgenetics.com.
CONTACT: Investors, Melanie Friedman of Stern Investor Relations,
+1-212-362-1200, or Media, Catherine Cloft of LaVoie Group,
+1-978-745-4200, ext. 107, both for Interleukin Genetics, Inc.
Web site: http://www.ilgenetics.com//
